Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Soichi Sugitani"'
Autor:
Naruhiro Kimura, Toru Setsu, Yoshihisa Arao, Norihiro Sakai, Yusuke Watanabe, Hiroyuki Abe, Hiroteru Kamimura, Akira Sakamaki, Takeshi Yokoo, Kenya Kamimura, Atsunori Tsuchiya, Akihiko Osaki, Kentarou Igarashi, Nobuo Waguri, Masahiko Yanagi, Toru Takahashi, Soichi Sugitani, Yuka Kobayashi, Masaaki Takamura, Akira Yoshikawa, Toru Ishikawa, Toshiaki Yoshida, Toshiaki Watanabe, Hitoshi Bannai, Tomoyuki Kubota, Kazuhiro Funakoshi, Hiroto Wakabayashi, So Kurita, Norio Ogata, Masashi Watanabe, Yuhsaku Mita, Shigeki Mori, Motoya Sugiyama, Toru Miyajima, Sumio Takahashi, Shuichi Sato, Kisei Ishizuka, Hironobu Ohta, Yutaka Aoyagi, Shuji Terai
Publikováno v:
JGH Open, Vol 6, Iss 8, Pp 577-586 (2022)
Abstract Background and Aim Symptoms of primary biliary cholangitis (PBC) frequently impair one's quality of life (QOL). Nonetheless, with improved treatment, the prognosis of PBC also improves. QOL plays an important role in patients with PBC. In th
Externí odkaz:
https://doaj.org/article/00155ff6b17b4c6ea105600566ce3d49
Autor:
Akira Sakamaki, Masaaki Takamura, Norihiro Sakai, Yusuke Watanabe, Yoshihisa Arao, Naruhiro Kimura, Toru Setsu, Hiroyuki Abe, Takeshi Yokoo, Hiroteru Kamimura, Shunsuke Tsubata, Nobuo Waguri, Toru Ishikawa, Hirokazu Kawai, Soichi Sugitani, Tomomi Sato, Kazuhiro Funakoshi, Masashi Watanabe, Kentarou Igarashi, Kenya Kamimura, Atsunori Tsuchiya, Yutaka Aoyagi, Shuji Terai
Publikováno v:
PLoS ONE, Vol 17, Iss 2, p e0263464 (2022)
Due to the developments in the treatment for hepatitis, it is possible to prevent the progression of liver fibrosis and improve patients' prognosis even if it has already led to liver cirrhosis (LC). Consequently, a two-step study was conducted. To b
Externí odkaz:
https://doaj.org/article/8a6311bc1dd14a26a74fee6f948e59ea
Publikováno v:
Case Reports in Medicine, Vol 2013 (2013)
Hepatic angiomyolipoma (AML) is notoriously difficult to diagnose without an invasive surgery even with the recent development of the various imaging modalities. Additionally, recent reports showed its malignant behavior after the surgery; it is impo
Externí odkaz:
https://doaj.org/article/edf4cf53b2844d5da188e44dc14143ae
Autor:
Naruhiro Kimura, Yuka Kobayashi, Motoya Sugiyama, Shuichi Sato, Nobuo Waguri, Toru Setsu, So Kurita, Norio Ogata, Tomoyuki Kubota, Toru Ishikawa, Soichi Sugitani, Hiroto Wakabayashi, Akihiko Osaki, Yasunobu Matsuda, Toru Takahashi, Masafumi Takatsuna, Toshiaki Yoshida, Atsunori Tsuchiya, Kazuhiro Funakoshi, Sumio Takahashi, Shuji Terai, Akira Yoshikawa, Hitoshi Ban-Nai, Masahiko Yanagi, Hironobu Ohta, Masaaki Takamura, Yutaka Aoyagi, Toru Miyajima, Shigeki Mori, Toshiaki Watanabe, Yuhsaku Mita, Kisei Ishizuka, Masashi Watanabe
Publikováno v:
Hepatology Research. 51:166-175
AIM Disease characteristics of primary biliary cholangitis have changed recently. However, detailed studies on the subject have been limited. Therefore, we aimed to clarify disease characteristics of patients with recent primary biliary cholangitis u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8278333a2471fd9c65781daa2056431d
https://doi.org/10.1111/hepr.13586
https://doi.org/10.1111/hepr.13586
Autor:
Ryo Goto, Satoshi Abe, Kohei Ogawa, Isao Sakaida, Takuro Nagoya, Yoshizu Nozawa, Soichi Sugitani, Akira Sakamaki, Koichi Fujisawa, Makoto Furutani-Seiki, Yoko Shinagawa-Kobayashi, Norihiro Sakai, Kenya Kamimura, Ryosuke Inoue, Naoto Koyama, Shuji Terai, Takeshi Yokoo, Masahiko Yanagi, Hiroshi Nishina
Publikováno v:
Biochemical and Biophysical Research Communications. 496:556-561
Background Sorafenib (SFN) is an anti-angiogenic chemotherapeutic that prolongs survival of patients with hepatocellular carcinoma (HCC); its side effects, including vascular damages such as hand-foot syndrome (HFS), are a major cause of therapy disc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::663d26871151868dc619bc27ca6890b9
https://doi.org/10.1016/j.bbrc.2018.01.057
https://doi.org/10.1016/j.bbrc.2018.01.057
Autor:
Kenya Kamimura, Satoshi Yamagiwa, Atsunori Tsuchiya, Soichi Sugitani, Nobuo Waguri, Shuji Terai, Toru Ishikawa, Masaaki Takamura, Hirokazu Kawai
Publikováno v:
International Journal of Medical Sciences
Objectives: To determine whether the soluble programmed cell death ligand 1 (sPD-L1) levels in patients with chronic hepatitis C (CHC) are associated with the clinical features of the disease and the efficacy of treatment, including interferon (IFN)-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ead143597a2152e99669d5d7c1b3f96f
http://europepmc.org/articles/PMC5441031
http://europepmc.org/articles/PMC5441031
Autor:
Hiroto Wakabayashi, Nobuo Waguri, Takashi Tsukishiro, Toshiaki Watanabe, Satoshi Yamagiwa, Toru Takahashi, Shogo Ohkoshi, Toru Ishikawa, Shuji Terai, Soichi Sugitani
Publikováno v:
World Journal of Hepatology
AIM To evaluate and compare the efficacy and safety of telaprevir (TVR)-and simeprevir (SMV)-based triple therapies in elderly patients, specifically patients aged 66 years or older. METHODS The present study enrolled 112 and 76 Japanese patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16b60b8859c09bd9e21a1fcb86a61692
http://europepmc.org/articles/PMC5316845
http://europepmc.org/articles/PMC5316845
Autor:
Yusuke Niwa, Yoko Shinagawa-Kobayashi, Masayoshi Ko, Masahiko Yanagi, Norihiro Sakai, Takuro Nagoya, Satoshi Abe, Takeshi Yokoo, Kenya Kamimura, Soichi Sugitani, Toru Setsu, Hiroteru Kamimura, Akira Sakamaki, Shuji Terai
Publikováno v:
Cancer Management and Research
Norihiro Sakai,1,* Kenya Kamimura,1,* Yoko Shinagawa-Kobayashi,1 Takuro Nagoya,1 Yusuke Niwa,1 Masayoshi Ko,1 Toru Setsu,1 Akira Sakamaki,1 Takeshi Yokoo,1 Satoshi Abe,1 Hiroteru Kamimura,1 Soichi Sugitani,2 Masahiko Yanagi,3 Shuji Terai11Division of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5381bda278534cb0515785ba075870b3
https://pubmed.ncbi.nlm.nih.gov/31191006
https://pubmed.ncbi.nlm.nih.gov/31191006
Publikováno v:
Digestive and Liver Disease. 49:453-454
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb8c3cbdd7d16872ff79904ba1ce6762
https://doi.org/10.1016/j.dld.2017.01.163
https://doi.org/10.1016/j.dld.2017.01.163
Autor:
Minoru Nomoto, Takuya Genda, Yutaka Aoyagi, Soichi Sugitani, Masaaki Takamura, Yasunobu Matsuda, Jun Inayoshi, Yasunori Tsuboi, Takafumi Ichida
Publikováno v:
Liver International. 24:432-436
Background: Dysregulation of cell proliferation is one of the most important features of human cancers including hepatocellular carcinoma (HCC). However, the molecular basis underlying the proliferation of HCC has not been fully clarified. Because a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4329543708fe81be1831522771b8444b
https://doi.org/10.1111/j.1478-3231.2004.0940.x
https://doi.org/10.1111/j.1478-3231.2004.0940.x